Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry Dimitrios A. Pappas Taylor Blachley Steve Zlotnick Jennie Best Kelechi Emeanuru Joel M. Kremer 10.6084/m9.figshare.11949234.v1 https://adisjournals.figshare.com/articles/figure/Methotrexate_Discontinuation_and_Dose_Decreases_After_Therapy_With_Tocilizumab_Results_From_the_Corrona_Rheumatoid_Arthritis_Registry/11949234 <p><strong>Article full text</strong></p> <p><br> The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.</p> <p><br> The above summary slide and plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). </p> <p>© The authors, CC-BY-NC 2020.<b> </b></p> 2020-03-19 12:58:53 Methotrexate Registry Rheumatoid arthritis Tocilizumab Plain Language Summary